Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
10 important updates for International HPV Awareness Day
Today is International HPV Awareness Day.
Study finds association between vitamin D, BMI and advanced cancer
Although extensive research has explored the potential association between vitamin D and cancer, studies have produced conflicting results.
Log in or Sign up for Free to view tailored content for your specialty!
National Comprehensive Cancer Network appoints chief scientific officer
Crystal S. Denlinger, MD, FACP, has been appointed senior vice president, chief scientific officer of National Comprehensive Cancer Network.
Medical University of South Carolina appoints chief of hematology, oncology
Craig Lockhart, MD, has been appointed chief of the division of hematology and oncology at Medical University of South Carolina.
Q&A: Longest survival among HCC patients seen with ‘breakthrough’ drug combination
In an exclusive interview with Healio Gastroenterology, Richard Finn, MD, discussed the results from a recent study of patients with hepatocellular carcinoma treated with combination therapy comprising atezolizumab, an immunotherapy drug and monoclonal antibody, and bevacizumab, another monoclonal antibody against the vascular endothelial growth factor (VEGF).
Current liver cancer screening protocols may miss at-risk Black individuals with HCV
Despite having better liver function at diagnosis, Black patients with hepatitis C virus tended to have more aggressive hepatocellular carcinoma tumors compared with other racial groups, according to a study published in Cancer.
Aspirin use may prolong survival for older patients with bladder, breast cancers
Any aspirin use and aspirin use at least three times per week appeared associated with improvements in survival outcomes among older adults with bladder and breast cancers, according to study results published in JAMA Network Open.
GERD may increase risk for cancers of the larynx, esophagus
GERD appeared to increase risk for esophageal adenocarcinoma, esophageal squamous cell carcinoma and laryngeal squamous cell carcinoma, according to results of a study published in Cancer.
PARP inhibitors may increase risk for myelodysplastic syndrome, AML
Poly(ADP-ribose) polymerase, or PARP, inhibitors appeared associated with increased risk for secondary myelodysplastic syndrome and acute myeloid leukemia compared with placebo among patients with cancer, according to study results.
VIDEO: Text message program offers support to patients diagnosed with CRC
In an exclusive video, Healio Gastroenterology spoke with Brian Dooreck, MD, of Gastrointestinal Diagnostic Centers in Pembroke Pines, Fla., about the colorectal cancer provider outreach program, or CRC POP.
-
Headline News
'Chroming': Dangerous huffing trend gains popularity on TikTok, led by minors
September 27, 20242 min read -
Headline News
FDA approves first new class of schizophrenia treatment in more than 30 years
September 27, 20243 min read -
Headline News
Follow the twists and turns toward better kidney care — more on the road ahead
September 27, 20241 min read
-
Headline News
'Chroming': Dangerous huffing trend gains popularity on TikTok, led by minors
September 27, 20242 min read -
Headline News
FDA approves first new class of schizophrenia treatment in more than 30 years
September 27, 20243 min read -
Headline News
Follow the twists and turns toward better kidney care — more on the road ahead
September 27, 20241 min read